Literature DB >> 24634682

Community-associated methicillin-resistant Staphylococcus aureus in a pediatric emergency department in Newfoundland and Labrador.

Erin Peebles1, Robert Morris2, Roger Chafe2.   

Abstract

BACKGROUND: First-generation cephalosporins and antistaphylococcal penicillins are typically the first choice for treating skin and soft tissue infections (SSTI), but are not effective for infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It is currently unclear what percentage of SSTIs is caused by community-associated MRSA in different regions in Canada.
OBJECTIVES: To determine the incidence of MRSA in children presenting to a pediatric emergency department with SSTI, and to determine which antibiotics were used to treat these infections.
METHODS: All visits to a pediatric emergency department were reviewed from April 15, 2010 to April 14, 2011. Diagnoses of cellulitis, abscess, impetigo, folliculitis and skin infection (not otherwise specified) were reviewed in detail to determine whether a culture was taken and which antibiotic was prescribed.
RESULTS: There were 367 cases of SSTI diagnosed over the study period. Forty-five (12.3%) patients had lesions that were swabbed for culture and sensitivity. S aureus was the most common organism found, with 14 (66%) methicillin-sensitive cases and seven (33%) methicillin-resistant cases. Of the seven cases of MRSA identified, only one patient had clear risk factors for hospital-acquired MRSA. First-generation cephalosporins were initially prescribed for 280 (76%) patients.
CONCLUSIONS: The overall incidence of MRSA in the population presenting to a pediatric emergency department in Newfoundland and Labrador appeared to be low, although only a small percentage of infections were cultured. At this time, there appears to be no need to change empirical antibiotic coverage, which remains a first-generation cephalosporin.

Entities:  

Keywords:  Emergency medicine; Methicillin-resistant Staphylococcus aureus; Pediatrics; Skin and soft tissue infections

Year:  2014        PMID: 24634682      PMCID: PMC3950990          DOI: 10.1155/2014/267901

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  21 in total

1.  Changes in community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections presenting to the pediatric emergency department: comparing 2003 to 2008.

Authors:  Mia L Karamatsu; Andrea W Thorp; Lance Brown
Journal:  Pediatr Emerg Care       Date:  2012-02       Impact factor: 1.454

2.  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-08-20       Impact factor: 17.586

3.  Epidemiology of methicillin-resistant Staphylococcus aureus at a pediatric healthcare system, 1991-2003.

Authors:  Jessica Jungk; Kathryn Como-Sabetti; Patricia Stinchfield; Patricia Ackerman; Kathleen Harriman
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Thomas R Wallin; H Gene Hern; Bradley W Frazee
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

Review 5.  Health care-associated MRSA versus community-associated MRSA.

Authors:  Temujin T Chavez; Catherine F Decker
Journal:  Dis Mon       Date:  2008-12       Impact factor: 3.800

6.  A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community.

Authors:  G Taylor; T Kirkland; K Kowalewska-Grochowska; Y Wang
Journal:  Can J Infect Dis       Date:  1990

7.  Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.

Authors:  F M Hussain; S Boyle-Vavra; C D Bethel; R S Daum
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

8.  Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Blanca E Gonzalez; Gerardo Martinez-Aguilar; Kristina G Hulten; Wendy A Hammerman; Jorge Coss-Bu; Anna Avalos-Mishaan; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

9.  Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance.

Authors:  Kathryn Como-Sabetti; Kathleen H Harriman; Jessica M Buck; Anita Glennen; David J Boxrud; Ruth Lynfield
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

10.  Methicillin-resistant Staphylococcus aureus in community-acquired skin infections.

Authors:  Gregory J Moran; Ricky N Amii; Frederick M Abrahamian; David A Talan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  1 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.

Authors:  Kassandra Loewen; Yoko Schreiber; Mike Kirlew; Natalie Bocking; Len Kelly
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.